GlassScriptPhysician profile
Elizabeth Morris
NPI 1346869948
$3,085.56
in general payments reported to CMS, 2019-2025
17 companies · $1,743 in 2025
The $1,743 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $58.33 · 2022: $245 · 2023: $645 · 2024: $394 · 2025: $1,743.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,783.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,782.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,131.88 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $489.73 | 2023-2025 | Caplyta |
| Novo Nordisk INC | $361.70 | 2021-2025 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $295.65 | 2022-2025 | Jardiance |
| Lilly USA, LLC | $128.29 | 2022-2025 | Zepbound, Mounjaro |
| Amgen INC. | $121.11 | 2023-2025 | Repatha, Otezla, Otezla |
| Fresenius USA Marketing, INC. | $98.85 | 2023 | Velphoro |
| Abiomed | $90.30 | 2025 | |
| Abbvie INC. | $76.78 | 2024-2025 | |
| Exact Sciences Corporation | $66.69 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Pfizer INC. | $55.70 | 2023-2025 | |
| Organon LLC | $54.47 | 2022-2023 | Nexplanon |
| Glaxosmithkline, LLC. | $32.78 | 2023-2024 | Trelegy Ellipta |
| Stryker Corporation | $26.01 | 2025 | Clottriever Bold Catheter |
| Biogen, INC. | $23.99 | 2025 | Skyclarys |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $18.02 | 2024 | Capvaxive, Gardasil 9, Vaxelis |
| Corcept Therapeutics | $13.61 | 2023 | Korlym |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.